Literature DB >> 21048807

Potential role of selected biomarkers for predicting the presence and extent of coronary artery disease.

Martin Griva1, Robert Naplava, Milada Spendlikova, Jiri Jarkovsky, Ota Hlinomaz, Cestmir Cihalik.   

Abstract

INTRODUCTION: Since atherosclerosis may in part be an inflammatory disease, circulatory factors related to inflammation may be predictors of coronary artery disease. The aim of this study was to evaluate the association between the level of some circulating biomarkers and the extent of coronary artery disease.
METHODS: Blood samples were taken from 128 patients with stable forms of coronary heart disease. Macrophage chemoattractant protein-1 (MCP-1), matrix-metalloproteinase-3 (MMP-3), soluble CD40 ligand (sCD40L) and soluble tumour necrosis factor receptor-2 (sTNFR2) were measured by ELISA. Coronary angiography and grading with the SYNTAX score followed.
RESULTS: There was no significant interdependence of circulating MCP-1, sCD40L, sTNFR2 levels and SYNTAX score. MMP-3 levels were significantly different in subgroup with coronary artery disease (SYNTAX score > 0): 38.1 µg/l (13.6; 84.1) and subgroup without coronary artery disease (SYNTAX score = 0): 20.4 µg/l (13.1; 82.8), p=0.001. According to the Spearman correlation coefficient there was significant association between MMP-3 level and SYNTAX score (0.358, a=0.05).
CONCLUSIONS: Our data suggest association between the extent of coronary artery disease and circulating MMP-3. We failed to demonstrate any association with the other investigated biomarkers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048807     DOI: 10.5507/bp.2010.033

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  1 in total

1.  Serum neutrophil gelatinase-associated lipocalin levels are correlated with the complexity and the severity of atherosclerosis in acute coronary syndrome.

Authors:  Korhan Soylu; Gökhan Aksan; Gökay Nar; Metin Özdemir; Okan Gülel; Sinan İnci; Aytekin Aksakal; Ayşegül İdil Soylu; Özcan Yılmaz
Journal:  Anatol J Cardiol       Date:  2014-07-16       Impact factor: 1.596

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.